Literature DB >> 16024917

CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance.

Jeltje R Goudriaan1, Marion A M den Boer, Patrick C N Rensen, Maria Febbraio, Folkert Kuipers, Johannes A Romijn, Louis M Havekes, Peter J Voshol.   

Abstract

CD36 is involved in high-affinity peripheral FFA uptake. CD36-deficient (cd36(-)(/)(-)) mice exhibit increased plasma FFA and triglyceride (TG) levels. The aim of the present study was to elucidate the cause of the increased plasma TG levels in cd36(-)(/)(-) mice. cd36(-)(/)(-) mice showed no differences in hepatic VLDL-TG production or intestinal [(3)H]TG uptake compared with wild-type littermates. cd36(-)(/)(-) mice showed a 2-fold enhanced postprandial TG response upon an intragastric fat load (P < 0.05), with a concomitant 2.5-fold increased FFA response (P < 0.05), suggesting that the increased FFA in cd36(-/-) mice may impair LPL-mediated TG hydrolysis. Postheparin LPL levels were not affected. However, the in vitro LPL-mediated TG hydrolysis rate as induced by postheparin plasma of cd36(-)(/)(-) mice in the absence of excess FFA-free BSA was reduced 2-fold compared with wild-type plasma (P < 0.05). This inhibition was relieved upon the addition of excess FFA-free BSA. Likewise, increasing plasma FFA in wild-type mice to the levels observed in cd36(-)(/)(-) mice by infusion prolonged the plasma half-life of glycerol tri[(3)H]oleate-labeled VLDL-like emulsion particles by 2.5-fold (P < 0.05). We conclude that the increased plasma TG levels observed in cd36(-)(/)(-) mice are caused by decreased LPL-mediated hydrolysis of TG-rich lipoproteins resulting from FFA-induced product inhibition of LPL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024917     DOI: 10.1194/jlr.M500112-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  34 in total

1.  Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells.

Authors:  May Brundert; Joerg Heeren; Martin Merkel; Antonella Carambia; Johannes Herkel; Peter Groitl; Thomas Dobner; Rajasekhar Ramakrishnan; Kathryn J Moore; Franz Rinninger
Journal:  J Lipid Res       Date:  2011-01-09       Impact factor: 5.922

Review 2.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

3.  Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Qiaoling Yao; Shannon Bevans-Fonti; James Poole; Luciano F Drager; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.310

4.  The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat.

Authors:  Tomomi Yamazaki; Kyoko Kishimoto; Osamu Ezaki
Journal:  J Lipid Res       Date:  2012-06-26       Impact factor: 5.922

Review 5.  Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis.

Authors:  Vincenza Cifarelli; Nada A Abumrad
Journal:  Compr Physiol       Date:  2018-03-26       Impact factor: 9.090

6.  CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine.

Authors:  Andromeda M Nauli; Fatiha Nassir; Shuqin Zheng; Qing Yang; Chun-Min Lo; Sarah B Vonlehmden; Dana Lee; Ronald J Jandacek; Nada A Abumrad; Patrick Tso
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

7.  Brown adipose tissue activity controls triglyceride clearance.

Authors:  Alexander Bartelt; Oliver T Bruns; Rudolph Reimer; Heinz Hohenberg; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Horst Weller; Christian Waurisch; Alexander Eychmüller; Philip L S M Gordts; Franz Rinninger; Karoline Bruegelmann; Barbara Freund; Peter Nielsen; Martin Merkel; Joerg Heeren
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

Review 8.  Cellular fatty acid uptake: a pathway under construction.

Authors:  Xiong Su; Nada A Abumrad
Journal:  Trends Endocrinol Metab       Date:  2009-01-29       Impact factor: 12.015

9.  Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.

Authors:  Pin Yue; Zhouji Chen; Fatiha Nassir; Carlos Bernal-Mizrachi; Brian Finck; Salman Azhar; Nada A Abumrad
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue.

Authors:  Ahmad Salameh; Alexes C Daquinag; Daniela I Staquicini; Zhiqiang An; Katherine A Hajjar; Renata Pasqualini; Wadih Arap; Mikhail G Kolonin
Journal:  JCI Insight       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.